{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T12:30:26Z","timestamp":1775219426909,"version":"3.50.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2023,5,11]],"date-time":"2023-05-11T00:00:00Z","timestamp":1683763200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,5,11]],"date-time":"2023-05-11T00:00:00Z","timestamp":1683763200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurochem Res"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1007\/s11064-023-03938-4","type":"journal-article","created":{"date-parts":[[2023,5,11]],"date-time":"2023-05-11T10:38:30Z","timestamp":1683801510000},"page":"2835-2846","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Acute Low Dose Naltrexone Increases \u03b2-Endorphin and Promotes Neuronal Recovery Following Hypoxia-Ischemic Stroke in Type-2 Diabetic Mice"],"prefix":"10.1007","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7013-7040","authenticated-orcid":false,"given":"Rashmi","family":"Kumari","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zainab Y.","family":"Kareem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia J.","family":"McLaughlin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,5,11]]},"reference":[{"issue":"4","key":"3938_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18103\/mra.v8i4.2081","volume":"8","author":"Kerstin Bettermann","year":"2020","unstructured":"Bettermann K, Sinha K, Kumari R, Simpson IA (2020) The stress-immune response in acute hyperglycemic stroke. Med Res Arch 8(4):1\u201314. https:\/\/doi.org\/10.18103\/mra.v8i4.2081","journal-title":"Med Res Arch"},{"key":"3938_CR2","doi-asserted-by":"publisher","first-page":"106061","DOI":"10.1016\/j.clineuro.2020.106061","volume":"195","author":"K Bettermann","year":"2020","unstructured":"Bettermann K, Sinha K, Kumari R, Fox C, Simpson IA (2020) The peripheral immune response in hyperglycemic stroke. Clin Neurol Neurosurg. 195:106061. https:\/\/doi.org\/10.1016\/j.clineuro.2020.106061","journal-title":"Clin Neurol Neurosurg."},{"issue":"1","key":"3938_CR3","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1111\/nyas.14583","volume":"1495","author":"MJ Krinock","year":"2021","unstructured":"Krinock MJ, Singhal NS (2021) Diabetes, stroke, and neuroresilience: looking beyond hyperglycemia. Ann N Y Acad Sci 1495(1):78\u201398. https:\/\/doi.org\/10.1111\/nyas.14583","journal-title":"Ann N Y Acad Sci"},{"issue":"10","key":"3938_CR4","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s11886-015-0633-5","volume":"17","author":"S Parker","year":"2015","unstructured":"Parker S, Ali Y (2015) Changing contraindications for t-PA in acute stroke: review of 20 years since NINDS. Curr Cardiol Rep 17(10):81. https:\/\/doi.org\/10.1007\/s11886-015-0633-5","journal-title":"Curr Cardiol Rep"},{"key":"3938_CR5","doi-asserted-by":"publisher","first-page":"101679","DOI":"10.1016\/j.pneurobio.2019.101679","volume":"182","author":"N Peyravian","year":"2019","unstructured":"Peyravian N, Dikici E, Deo S, Toborek M, Daunert S (2019) Opioid antagonists as potential therapeutics for ischemic stroke. Prog Neurobiol. 182:101679. https:\/\/doi.org\/10.1016\/j.pneurobio.2019.101679","journal-title":"Prog Neurobiol."},{"issue":"4","key":"3938_CR6","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1038\/sj.jcbfm.9600382","volume":"27","author":"R Kumari","year":"2007","unstructured":"Kumari R, Willing LB, Krady JK, Vannucci SJ, Simpson IA (2007) Impaired wound healing after cerebral hypoxia-ischemia in the diabetic mouse. J Cereb Blood Flow Metab 27(4):710\u2013718. https:\/\/doi.org\/10.1038\/sj.jcbfm.9600382","journal-title":"J Cereb Blood Flow Metab"},{"issue":"2","key":"3938_CR7","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1038\/jcbfm.2009.221","volume":"30","author":"R Kumari","year":"2010","unstructured":"Kumari R, Willing LB, Patel SD, Krady JK, Zavadoski WJ, Gibbs EM et al (2010) The PPAR-gamma agonist, darglitazone, restores acute inflammatory responses to cerebral hypoxia-ischemia in the diabetic ob\/ob mouse. J Cereb Blood Flow Metab 30(2):352\u2013360. https:\/\/doi.org\/10.1038\/jcbfm.2009.221","journal-title":"J Cereb Blood Flow Metab"},{"key":"3938_CR8","doi-asserted-by":"publisher","first-page":"104790","DOI":"10.1016\/j.neuint.2020.104790","volume":"139","author":"R Kumari","year":"2020","unstructured":"Kumari R, Bettermann K, Willing L, Sinha K, Simpson IA (2020) The role of neutrophils in mediating stroke injury in the diabetic db\/db mouse brain following hypoxia-ischemia. Neurochem Int. 139:104790. https:\/\/doi.org\/10.1016\/j.neuint.2020.104790","journal-title":"Neurochem Int."},{"key":"3938_CR9","doi-asserted-by":"publisher","first-page":"2392","DOI":"10.3389\/fimmu.2019.02392","volume":"10","author":"F Zhang","year":"2019","unstructured":"Zhang F, Zhao Q, Jiang Y, Liu N, Liu Q, Shi FD et al (2019) Augmented brain infiltration and activation of leukocytes after cerebral ischemia in type 2 diabetic mice. Front Immunol 10:2392. https:\/\/doi.org\/10.3389\/fimmu.2019.02392","journal-title":"Front Immunol"},{"issue":"4","key":"3938_CR10","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1007\/s43440-022-00382-z","volume":"74","author":"R Kumari","year":"2022","unstructured":"Kumari R, Willing L, Kimball SR, Simpson IA (2022) The effect of chronic exposure to metformin in a new type-2 diabetic NONcNZO10\/LtJ mouse model of stroke. Pharmacol Rep 74(4):696\u2013708. https:\/\/doi.org\/10.1007\/s43440-022-00382-z","journal-title":"Pharmacol Rep"},{"issue":"5","key":"3938_CR11","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1111\/j.1471-4159.1981.tb00437.x","volume":"36","author":"S Govoni","year":"1981","unstructured":"Govoni S, Yang HY (1981) Sex differences in the content of beta-endorphin and enkephalin-like peptides in the pituitary of obese (ob\/ob) mice. J Neurochem 36(5):1829\u20131833. https:\/\/doi.org\/10.1111\/j.1471-4159.1981.tb00437.x","journal-title":"J Neurochem"},{"issue":"10","key":"3938_CR12","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.2337\/diab.35.10.1143","volume":"35","author":"K Timmers","year":"1986","unstructured":"Timmers K, Voyles NR, Zalenski C, Wilkins S, Recant L (1986) Altered beta-endorphin, Met- and Leu-enkephalins, and enkephalin-containing peptides in pancreas and pituitary of genetically obese diabetic (db\/db) mice during development of diabetic syndrome. Diabetes 35(10):1143\u20131151. https:\/\/doi.org\/10.2337\/diab.35.10.1143","journal-title":"Diabetes"},{"issue":"4","key":"3938_CR13","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/0026-0495(90)90252-8","volume":"39","author":"K Timmers","year":"1990","unstructured":"Timmers K, Coleman DL, Voyles NR, Powell AM, R\u00f6kaeus A, Recant L (1990) Neuropeptide content in pancreas and pituitary of obese and diabetes mutant mice: strain and sex differences. Metabolism 39(4):378\u2013383. https:\/\/doi.org\/10.1016\/0026-0495(90)90252-8","journal-title":"Metabolism"},{"issue":"1","key":"3938_CR14","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1210\/endo-116-1-328","volume":"116","author":"J Greenberg","year":"1985","unstructured":"Greenberg J, Ellyin F, Pullen G, Ehrenpreis S, Singh SP, Cheng J (1985) Methionine-enkephalin and beta-endorphin levels in brain, pancreas, and adrenals of db\/db mice. Endocrinology 116(1):328\u2013331. https:\/\/doi.org\/10.1210\/endo-116-1-328","journal-title":"Endocrinology"},{"issue":"7","key":"3938_CR15","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1177\/1535370213492688","volume":"238","author":"PJ McLaughlin","year":"2013","unstructured":"McLaughlin PJ, Immonen JA, Zagon IS (2013) Topical naltrexone accelerates full-thickness wound closure in type 1 diabetic rats by stimulating angiogenesis. Exp Biol Med (Maywood). 238(7):733\u201343. https:\/\/doi.org\/10.1177\/1535370213492688","journal-title":"Exp Biol Med (Maywood)."},{"issue":"2","key":"3938_CR16","doi-asserted-by":"publisher","first-page":"42","DOI":"10.33696\/immunology.1.018","volume":"2","author":"PJ McLaughlin","year":"2020","unstructured":"McLaughlin PJ, Sassani JW, Zagon IS (2020) Naltrexone as a Novel Therapeutic for Diabetic Corneal Complications. J Cell Immunol. 2(2):42\u20136. https:\/\/doi.org\/10.33696\/immunology.1.018","journal-title":"J Cell Immunol."},{"issue":"6","key":"3938_CR17","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1016\/j.bcp.2012.05.018","volume":"84","author":"PJ McLaughlin","year":"2012","unstructured":"McLaughlin PJ, Zagon IS (2012) The opioid growth factor-opioid growth factor receptor axis: homeostatic regulator of cell proliferation and its implications for health and disease. Biochem Pharmacol 84(6):746\u2013755. https:\/\/doi.org\/10.1016\/j.bcp.2012.05.018","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"3938_CR18","doi-asserted-by":"publisher","first-page":"169","DOI":"10.3748\/wjg.v9.i1.169","volume":"9","author":"XH Liu","year":"2003","unstructured":"Liu XH, Huang DA, Yang FY, Hao YS, Du GG, Li PF et al (2003) A new cytokine: the possible effect pathway of methionine enkephalin. World J Gastroenterol. 9(1):169\u201373. https:\/\/doi.org\/10.3748\/wjg.v9.i1.169","journal-title":"World J Gastroenterol."},{"issue":"6","key":"3938_CR19","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1089\/wound.2014.0543","volume":"3","author":"JA Immonen","year":"2014","unstructured":"Immonen JA, Zagon IS, McLaughlin PJ (2014) Topical naltrexone as treatment for type 2 diabetic cutaneous wounds. Adv Wound Care 3(6):419\u201327. https:\/\/doi.org\/10.1089\/wound.2014.0543","journal-title":"Adv Wound Care"},{"issue":"3","key":"3938_CR20","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.bcp.2015.06.016","volume":"97","author":"PJ McLaughlin","year":"2015","unstructured":"McLaughlin PJ, Zagon IS (2015) Duration of opioid receptor blockade determines biotherapeutic response. Biochem Pharmacol 97(3):236\u2013246. https:\/\/doi.org\/10.1016\/j.bcp.2015.06.016","journal-title":"Biochem Pharmacol"},{"key":"3938_CR21","doi-asserted-by":"publisher","first-page":"102325","DOI":"10.1016\/j.npep.2023.102325","volume":"99","author":"ZY Kareem","year":"2023","unstructured":"Kareem ZY, McLaughlin PJ, Kumari R (2023) Opioid growth factor receptor: anatomical distribution and receptor colocalization in neurons of the adult mouse brain. Neuropeptides. 99:102325. https:\/\/doi.org\/10.1016\/j.npep.2023.102325","journal-title":"Neuropeptides."},{"issue":"8241","key":"3938_CR22","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/s0140-6736(81)90524-9","volume":"2","author":"DS Baskin","year":"1981","unstructured":"Baskin DS, Hosobuchi Y (1981) Naloxone reversal of ischaemic neurological deficits in man. Lancet 2(8241):272\u2013275. https:\/\/doi.org\/10.1016\/s0140-6736(81)90524-9","journal-title":"Lancet"},{"issue":"4","key":"3938_CR23","first-page":"1","volume":"10","author":"T Schwaiger","year":"2018","unstructured":"Schwaiger T (2018) The uses of low-dose Naltrexone in clinical practice. Nat Med J 10(4):1\u201312","journal-title":"Nat Med J"},{"issue":"3","key":"3938_CR24","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.pneurobio.2007.12.001","volume":"84","author":"NP Hailer","year":"2008","unstructured":"Hailer NP (2008) Immunosuppression after traumatic or ischemic CNS damage: it is neuroprotective and illuminates the role of microglial cells. Prog Neurobiol 84(3):211\u2013233. https:\/\/doi.org\/10.1016\/j.pneurobio.2007.12.001","journal-title":"Prog Neurobiol"},{"issue":"4","key":"3938_CR25","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1177\/1091581815584918","volume":"34","author":"T Ramani","year":"2015","unstructured":"Ramani T, Auletta CS, Weinstock D, Mounho-Zamora B, Ryan PC, Salcedo TW et al (2015) Cytokines: the good, the bad, and the deadly. Int J Toxicol 34(4):355\u2013365. https:\/\/doi.org\/10.1177\/1091581815584918","journal-title":"Int J Toxicol"},{"issue":"1","key":"3938_CR26","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1172\/jci18336","volume":"113","author":"L Zhang","year":"2004","unstructured":"Zhang L, Nair A, Krady K, Corpe C, Bonneau RH, Simpson IA et al (2004) Estrogen stimulates microglia and brain recovery from hypoxia-ischemia in normoglycemic but not diabetic female mice. J Clin Invest 113(1):85\u201395. https:\/\/doi.org\/10.1172\/jci18336","journal-title":"J Clin Invest"},{"issue":"1","key":"3938_CR27","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1097\/00004647-200101000-00007","volume":"21","author":"SJ Vannucci","year":"2001","unstructured":"Vannucci SJ, Willing LB, Goto S, Alkayed NJ, Brucklacher RM, Wood TL et al (2001) Experimental stroke in the female diabetic, db\/db, mouse. J Cereb Blood Flow Metab 21(1):52\u201360. https:\/\/doi.org\/10.1097\/00004647-200101000-00007","journal-title":"J Cereb Blood Flow Metab"},{"issue":"5","key":"3938_CR28","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1111\/j.1471-4159.2011.07487.x","volume":"119","author":"R Kumari","year":"2011","unstructured":"Kumari R, Willing LB, Patel SD, Baskerville KA, Simpson IA (2011) Increased cerebral matrix metalloprotease-9 activity is associated with compromised recovery in the diabetic db\/db mouse following a stroke. J Neurochem 119(5):1029\u20131040. https:\/\/doi.org\/10.1111\/j.1471-4159.2011.07487.x","journal-title":"J Neurochem"},{"issue":"2","key":"3938_CR29","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/jcbfm.1990.47","volume":"10","author":"RA Swanson","year":"1990","unstructured":"Swanson RA, Morton MT, Tsao-Wu G, Savalos RA, Davidson C, Sharp FR (1990) A semiautomated method for measuring brain infarct volume. J Cereb Blood Flow Metab. 10(2):290\u20133","journal-title":"J Cereb Blood Flow Metab."},{"issue":"2","key":"3938_CR30","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.jneumeth.2007.11.003","volume":"168","author":"SB Shelton","year":"2008","unstructured":"Shelton SB, Pettigrew DB, Hermann AD, Zhou W, Sullivan PM, Crutcher KA et al (2008) A simple, efficient tool for assessment of mice after unilateral cortex injury. J Neurosci Methods. 168(2):431\u201342. https:\/\/doi.org\/10.1016\/j.jneumeth.2007.11.003","journal-title":"J Neurosci Methods."},{"key":"3938_CR31","doi-asserted-by":"publisher","DOI":"10.3791\/54719","author":"J O'Brien","year":"2016","unstructured":"O\u2019Brien J, Hayder H, Peng C (2016) Automated quantification and analysis of cell counting procedures using imagej plugins. J Vis Exp. https:\/\/doi.org\/10.3791\/54719","journal-title":"J Vis Exp"},{"key":"3938_CR32","doi-asserted-by":"publisher","first-page":"539","DOI":"10.3390\/diabetology3040041","volume":"3","author":"LW Rashmi Kumari","year":"2022","unstructured":"Rashmi Kumari LW (2022) Glucocorticoid receptors blockers pretreatment did not improve infarct volume in type-2 diabetic mouse model of stroke. Diabetology 3:539\u2013548. https:\/\/doi.org\/10.3390\/diabetology3040041","journal-title":"Diabetology"},{"key":"3938_CR33","doi-asserted-by":"publisher","first-page":"4273290","DOI":"10.1155\/2019\/4273290","volume":"2019","author":"Y Liu","year":"2019","unstructured":"Liu Y, Fu N, Su J, Wang X, Li X (2019) rapid enkephalin delivery using exosomes to promote neurons recovery in ischemic stroke by inhibiting neuronal p53\/caspase-3. Biomed Res Int 2019:4273290. https:\/\/doi.org\/10.1155\/2019\/4273290","journal-title":"Biomed Res Int"},{"issue":"2","key":"3938_CR34","doi-asserted-by":"publisher","first-page":"158","DOI":"10.2478\/v10039-011-0051-x","volume":"56","author":"D Owczarek","year":"2011","unstructured":"Owczarek D, Cibor D, Mach T, Cie\u015bla A, Pierzcha\u0142a-Koziec K, Sa\u0142apa K et al (2011) Met-enkephalins in patients with inflammatory bowel diseases. Adv Med Sci 56(2):158\u2013164. https:\/\/doi.org\/10.2478\/v10039-011-0051-x","journal-title":"Adv Med Sci"},{"issue":"15","key":"3938_CR35","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1177\/1535370217724791","volume":"242","author":"MD Ludwig","year":"2017","unstructured":"Ludwig MD, Zagon IS, McLaughlin PJ (2017) Featured Article: Serum [Met(5)]-enkephalin levels are reduced in multiple sclerosis and restored by low-dose naltrexone. Exp Biol Med 242(15):1524\u201333. https:\/\/doi.org\/10.1177\/1535370217724791","journal-title":"Exp Biol Med"},{"issue":"4","key":"3938_CR36","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/s0143-4179(96)90022-0","volume":"30","author":"MG Kolta","year":"1996","unstructured":"Kolta MG, Ngong JM, Rutledge LP, Pierzchala K, Van Loon GR (1996) Endogenous opioid peptide mediation of hypoalgesic response in long-term diabetic rats. Neuropeptides 30(4):335\u2013344. https:\/\/doi.org\/10.1016\/s0143-4179(96)90022-0","journal-title":"Neuropeptides"},{"issue":"1","key":"3938_CR37","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/0143-4179(92)90152-m","volume":"21","author":"MG Kolta","year":"1992","unstructured":"Kolta MG, Pierzchala K, Houdi AA, Van Loon GR (1992) Effect of diabetes on the levels of two forms of Met-enkephalin in plasma and peripheral tissues of the rat. Neuropeptides 21(1):55\u201363. https:\/\/doi.org\/10.1016\/0143-4179(92)90152-m","journal-title":"Neuropeptides"},{"issue":"3","key":"3938_CR38","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1111\/j.1365-2826.1990.tb00422.x","volume":"2","author":"BA Barron","year":"1990","unstructured":"Barron BA, Pierzchala K, Loon GR (1990) Source of stress-induced increase in plasma met-enkephalin in rats: contribution of adrenal medulla and\/or sympathetic nerves*. J Neuroendocrinol 2(3):381\u2013388. https:\/\/doi.org\/10.1111\/j.1365-2826.1990.tb00422.x","journal-title":"J Neuroendocrinol"},{"issue":"4","key":"3938_CR39","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1111\/j.1476-5381.1997.tb06829.x","volume":"120","author":"J Hughes","year":"1997","unstructured":"Hughes J, Kosterlitz HW, Smith TW (1997) The distribution of methionine-enkephalin and leucine-enkephalin in the brain and peripheral tissues. Br J Pharmacol. 120(4):428\u201336. https:\/\/doi.org\/10.1111\/j.1476-5381.1997.tb06829.x","journal-title":"Br J Pharmacol."},{"issue":"4","key":"3938_CR40","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1007\/s10067-014-2517-2","volume":"33","author":"J Younger","year":"2014","unstructured":"Younger J, Parkitny L, McLain D (2014) The use of low-dose naltrexone (LDN) as a novel anti-inflammatory treatment for chronic pain. Clin Rheumatol 33(4):451\u2013459. https:\/\/doi.org\/10.1007\/s10067-014-2517-2","journal-title":"Clin Rheumatol"},{"issue":"2","key":"3938_CR41","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1097\/AIA.0b013e318034194e","volume":"45","author":"JM Zhang","year":"2007","unstructured":"Zhang JM, An J (2007) Cytokines, inflammation, and pain. Int Anesthesiol Clin 45(2):27\u201337. https:\/\/doi.org\/10.1097\/AIA.0b013e318034194e","journal-title":"Int Anesthesiol Clin"},{"key":"3938_CR42","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines5020016","author":"L Parkitny","year":"2017","unstructured":"Parkitny L, Younger J (2017) Reduced pro-inflammatory cytokines after eight weeks of low-dose naltrexone for fibromyalgia. Biomedicines. https:\/\/doi.org\/10.3390\/biomedicines5020016","journal-title":"Biomedicines"},{"issue":"4\u20136","key":"3938_CR43","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/0143-4179(85)90014-9","volume":"5","author":"DS Baskin","year":"1985","unstructured":"Baskin DS, Kuroda H, Hosobuchi Y, Lee NM (1985) Treatment of stroke with opiate antagonists\u2013effects of exogenous antagonists and dynorphin 1\u201313. Neuropeptides 5(4\u20136):307\u2013310. https:\/\/doi.org\/10.1016\/0143-4179(85)90014-9","journal-title":"Neuropeptides"},{"key":"3938_CR44","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.bbi.2015.03.005","volume":"48","author":"PM Grace","year":"2015","unstructured":"Grace PM, Shimizu K, Strand KA, Rice KC, Deng G, Watkins LR et al (2015) (+)-Naltrexone is neuroprotective and promotes alternative activation in the mouse hippocampus after cardiac arrest\/cardiopulmonary resuscitation. Brain Behav Immun. 48:115\u201322. https:\/\/doi.org\/10.1016\/j.bbi.2015.03.005","journal-title":"Brain Behav Immun."}],"container-title":["Neurochemical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-023-03938-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11064-023-03938-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-023-03938-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,19]],"date-time":"2023-07-19T04:19:17Z","timestamp":1689740357000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11064-023-03938-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,11]]},"references-count":44,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["3938"],"URL":"https:\/\/doi.org\/10.1007\/s11064-023-03938-4","relation":{},"ISSN":["0364-3190","1573-6903"],"issn-type":[{"value":"0364-3190","type":"print"},{"value":"1573-6903","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,11]]},"assertion":[{"value":"19 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 April 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Experimental procedures involving animals were conducted in accordance with NIH guidelines on the Care and Use of Laboratory Animals and approved by the institution\u2019s Animal Care and Use Committee of Pennsylvania State University (Ethics Approval Number: PROTO201901187).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}